Schizophrenia and apolipoprotein e gene polymorphism in Serbian population

International Journal of Neuroscience

Volumn 120, Issue 7, 2010, Pages 502-506

  Kecmanović, Miljana ^a   Dobričić, Valerija ^a   Dimitrijević, Rajna ^a   Keckarević, Dušan ^a   Savić Pavićević, Dušanka ^a   Keckarević Marković, Milica ^a   Ivkovic, Maja ^b   Romac, Stanka ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Institute of Psychiatry   (Serbia)

Author keywords

APOE; Genotyping; Neuroleptic; Schizophrenia; Serbian population

Indexed keywords

APOLIPOPROTEIN E; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; SCHIZOPHRENIA; SERBIA; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ADULT; ALLELES; ANTIPSYCHOTIC AGENTS; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; DRUG RESISTANCE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; RISK FACTORS; SCHIZOPHRENIA; SERBIA; YOUNG ADULT;

EID: 77954195637     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207451003765956     Document Type: Article

References (30)

1. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, 4th ed. Washington, DC: Author.
2. Arnold, S. E., Joo, E., Martinoli, M. G., et al. (1997). Apolipoprotein E gentotype in schizophrenia: Frequency, age of onset, and neuropathologic features. Neuroreport, 8, 1523-1526.
3. Baron, M. (2001). Genetic of schizophrenia and the new millennium: Profess and pitfalls. The American Journal of Human Genetics, 68, 299-312.
4. Bassam, B. J., & Gresshoff, P. M. (2007). Silver staining DNA in polyacrylamide gels. Nature Protocol, 2, 2649-2654.
5. Chen, J. Y., Hong, C. J., Chiu, H. J., et al. (1999). Apolipoprotein E genotype and schizophrenia. Neuropsychobiology, 39, 141-143.
6. Corder, E.H., Saunders, A.M., Strittmatter,W. J., et al. (1993).Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921-923.
7. Corder, E. H., Saunders, A. M., Risch, N. J., et al. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics, 7, 180-184.
8. Durany, N., Riederer, P., & Cruz-Sanchez, F. F. (2000). Apolipoprotein E genotype in Spanish schizophrenic patients. Psychiatric Genetics, 10, 73-77.
9. Fernandez, T., Yan, W. L., Hamburger, S., et al. (1999). Apolipoprotein E alleles in childhood-onset schizophrenia. American Journal of Medical Genetics, 88, 211-213.
10. Fisman, M., Rabheru, K., Hegele, R. A., et al. (2001). Apolipoprotein E polymorphism and response to electroconvulsive therapy. Journal of Extracorporeal Technology, 17, 11-14.
11. Hallman, D. M., Boerwinkle, E., Saha, N., et al. (1991). The Apolipoprotein polymorphism: A comparison of the allele frequencies and effects in nine populations. American Journal of Human Genetics, 49, 338-349.
12. Harrington, C. R., Roth,M., Xuereb, J. H., et al. (1995). Apolipoprotein E type epsilon 4 allele frequency is increased in patients with schizophrenia. Neuroscience Letters, 202, 101-104.
13. Hixson, J. E., & Vernier, D. T. (1990). Restriction isotype of human apolipoprotein E polymorphism by gene amplification and cleavage with HhaI. Journal of Lipid Research, 31, 545-548.
14. Hong, C. J., Yu, Y. W., Lin, C. H., et al. (2000). Association study of apolipoprotein E epsilon 4 with clinical phenotype and clozapine response in schizophrenia. Neuropsychobiology, 42, 172-174.
15. Igata-Yi, R., Igata, T., Ishizuka, K., et al. (1997). Apolipoprotein E genotype and psychosis. Biological Psychiatry, 41, 906-908.
16. Kampman,O., Anttila, S., Illi, A., et al. (2004) Apolipoprotein E polymorphism is associated with age of onset in schizophrenia. Journal of Human Genetics, 49, 355-359.
17. Kimura, T., Shono, M., Yokota, S., Igata-Yi R, et al. (2000). Apolipoprotein E epsilon3 allele is not a risk factor of schizophrenia: A study of 314 Japanese patients. Neuropsychobiology, 42, 66-68.
18. Kimura, T., Yokota, S., Igata-Yi, R., et al. (1997). Apolipoprotein E epsilon2 allele and early onset schizophrenia. Neuroscience Letters, 231, 53-55. (Pubitemid 27366287)
19. Kohn, Y., & Lerer, B. (2002). Genetics of schizophrenia a review of linkage findings. Israel Journal of Psychiatry and Related Sciences, 39, 340-351.
20. Liu,W., Breen, G., Zhang, J., et al. (2003). Association of APOE gene with schizophrenia in Chinese: A possible risc factor in times of malnutritition. Schizophrenia Research, 62, 225-230.
21. McGuffin, P., Tandon, K., & Corsico, A. (2003). Linkage and association studies of schizophrenia. Current Psychiatry Reports, 5, 121-127.
22. Murphy,G.M., Kremer, C., Rodrigues, H., et al. (2003).Mitrazepine versus paroxetine study group: The apolipoprotein E epsilon 4 allele and antidepresant efficacy in cognitively intact elderly depressed patients. Biological Psychiatry, 54, 665-673.
23. Olaisen, B., Teisberg, P., & Gedde-Dahl, T. Jr. (1982). The locus for apolipoprotein E (apoE) is linked to the complement component C3 (C3) locus of chromosome 19 in men. Human Genetics, 62, 233-236.
24. Pickar, D., Malhotra, A. K., Rooney, W., et al. (1997). Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia: Further negative evidence. Acta Psychiatrica Scandinavica, 105, 71-75.
25. Poirier, J. (1994). Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends in Neurosciences, 17, 525-530.
26. Rice, W. R. (1989). Analyzing tables of statistical tests. Evolution, 43, 223-225.
27. Saiz, P. A., Morales, B.,G-Portila,M. P., et al. (2002). Apolipoprotein E genotype and schizophrenia: Further negative evidence. Acta Psychiatrica Scandinavica, 105, 71-75.
28. Saunders, A. M., Strittmetter, W. J., Schmechel, D., et al. (1993). Association of apolipoprotein E allele epsilon 4 with late onset familial and sporadic Alzheimer's disease. Neurology, 43, 1467-1472. (Pubitemid 23230526)
29. Yoshizawa, T., Yamakawa-Kkobayashi, K., Komatsuzaki, Y., et al. (1994). Dose dependent association of apolipoprotein E allele epsilon 4 with late onset, sporadic Alzheimer's disease. Annals of Neurology, 36, 656-659.
30. Zannis, V. I., Breslow, J. L., Utermann, G., et al. (1982). Proposed nomenclature of apoE isoproteins, ApoE genotypes, and phenotypes. Journal of Lipid Research, 23, 911-914.